368 Integrative Transcriptomics and Network Analysis Reveals Core Genes Driving Meningioma Pathogenesis and Clinical Outcomes

View at publisher Summarise with VIRAT
Authors: Youssef M. Zohdy, Ali Mostafa Alawieh, Arman Jahangiri, Benjamin Siciliano, Leonardo Tariciotti, Alejandra Rodas, Justin Maldonado, Kimberly Bojanowski Hoang, Edjah Kweku-Ebura Nduom, Brian M. Howard, Daniel Louis Barrow, Aliaksandr Aksionau
+4 more Stewart G. Neill, Zhexing Wen, Gustavo Pradilla, Tomás Garzón-Muvdi
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

INTRODUCTION: Meningiomas are the most prevalent primary CNS tumors, commonly managed conservatively due to their benign histology. However, current histopathological grading inadequately captures tumor behavior. Molecular phenotyping represents a promising frontier for refining classification, yet no definitive prognostic biomarker panel has been established. METHODS: Transcriptomic profiling was performed on resected meningioma tissues and matched normal meninges. Differentially expressed genes (DEGs) were identified and functional annotation and protein–protein interaction (PPI) networks were constructed. Network topology was assessed to identify “rich-club” (RC) core genes. Correlations with WHO grade, recurrence, and survival were evaluated using GLMs, ROC analysis, and validation in an external cohort obtained with an independent center. RESULTS: Transcriptomic analysis identified 1,653 DEGs (725 upregulated, 928 downregulated). Upregulated genes were enriched for proliferation and angiogenesis, while downregulated genes reflected immune suppression, among others. Both DEG networks exhibited small-world and rich-club topology. RC subnetworks showed significantly higher connectivity (P < 0.001). Expression of RC genes correlated strongly with tumor grade (AUC = 0.879 up; AUC = 0.85 down; P < 0.01). External validation confirmed predictive accuracy for distinguishing low-grade from high-grade tumors (AUC = 0.798, P < 0.001). RC gene models predicted recurrence with high accuracy (AUC = 0.959, R2 = 0.53, PPV = 80%) and significantly predicted overall patient survival (AUC = 0.86, R2 = 0.451, PPV = 72%). High RC gene expression was associated with increased mortality risk (HR = 6.1, p = 0.014). CONCLUSIONS: This integrative transcriptomic and network-based analysis identified core molecular regulators in meningiomas with strong predictive power for histological grade, tumor recurrence, and overall patient survival. These RC genes offer promising biomarkers for stratified clinical management and potential therapeutic targeting.

Fields of Study & Subjects

Meningioma and schwannoma management Bone Tumor Diagnosis and Treatments Glioma Diagnosis and Treatment

Publication details

Journal / source
Neurosurgery
Volume
72
Issue
Supplement_1
Pages
100–100
Publication date
26 March 2026
Language
EN